Table 1.
Effects of orally administered OFE on oxidative status in the lungs and spleen of mice as determined in three different assays.
| Tissue | ORAC (Trolox equivalents, mM) | TBARS (nM/mg protein) | GSH (μM/mg protein) | |||
|---|---|---|---|---|---|---|
| Control | OFE | Control | OFE | Control | OFE | |
| Lung | 2.42 ± 0.61 | 3.60 ± 0.24* | 0.20 ± 0.02 | 0.12 ± 0.02* | 15.27 ± 3.14 | 24.36 ± 3.01*** |
| Spleen | 2.10 ± 0.68 | 3.97 ± 0.79*** | 0.57 ± 0.01 | 0.46 ± 0.05*** | 15.97 ± 1.13 | 25.23 ± 1.19*** |
OFE (1000 mg OFE/kg body weight in 200 μL normal saline) was orally administered daily for 14 days.
Data are expressed as mean ± standard deviation; n = 4; *P < 0.05, ***P < 0.01 as compared to (control) BALB/c mice given normal saline.